phenyl-n-tert-butylnitrone has been researched along with Arterial Occlusive Diseases in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Balogh, GT; Fischer, J; Gere, A; Kis-Varga, A; Könczöl, A; Vukics, K | 1 |
Hallenbeck, JM; Martin, D; Nawashiro, H | 1 |
Baethmann, A; Hungerhuber, E; Reulen, H; Schmid-Elsaesser, R; Zausinger, S | 1 |
3 other study(ies) available for phenyl-n-tert-butylnitrone and Arterial Occlusive Diseases
Article | Year |
---|---|
Nitrone derivatives of trolox as neuroprotective agents.
Topics: Animals; Antioxidants; Arterial Occlusive Diseases; Brain Ischemia; Cerebrovascular Circulation; Chromans; Free Radical Scavengers; Hydroxyl Radical; Infarction, Middle Cerebral Artery; Lipid Peroxidation; Mice; Neuroprotective Agents; Nitrogen Oxides; Structure-Activity Relationship | 2005 |
Neuroprotective effects of TNF binding protein in focal cerebral ischemia.
Topics: Animals; Arterial Occlusive Diseases; Biotin; Brain Ischemia; Cerebral Infarction; Cyclic N-Oxides; Deoxyuracil Nucleotides; DNA Fragmentation; Free Radical Scavengers; Interleukin 1 Receptor Antagonist Protein; Male; Mice; Mice, Inbred BALB C; Neurons; Neuroprotective Agents; Nitrogen Oxides; Phosphopyruvate Hydratase; Receptors, Interleukin-1; Receptors, Tumor Necrosis Factor; Receptors, Tumor Necrosis Factor, Type I; Sialoglycoproteins; Staining and Labeling; Tumor Necrosis Factor Decoy Receptors; Tumor Necrosis Factor-alpha | 1997 |
Neurological impairment in rats after transient middle cerebral artery occlusion: a comparative study under various treatment paradigms.
Topics: Animals; Arterial Occlusive Diseases; Blood Glucose; Blood Pressure; Cerebral Cortex; Cyclic N-Oxides; Hematocrit; Hemoglobins; Hypothermia, Induced; Infarction, Middle Cerebral Artery; Laser-Doppler Flowmetry; Male; Motor Activity; Neurologic Examination; Neuroprotective Agents; Nitrogen Oxides; Postural Balance; Psychomotor Performance; Rats; Recovery of Function; Reperfusion Injury; Time Factors | 2000 |